On January 3, 2026, Mr. Luo Wenhua, President of the Health Industry Branch of the Ningbo Vocational Association, led a delegation to Zhejiang Tianyuan Biotechnology Co., Ltd. for an inspection and guidance visit, during which the Branch Council (Enlarged) Meeting was successfully convened. Mr. Jiao Mingming, General Manager of the company, together with his team, warmly received the distinguished guests.

      The guests began their tour at the company’s Science and Technology Exhibition Hall, gaining an in-depth understanding of Tianyuan Biotech’s advanced technologies, research capabilities, and development history in the bio-health sector. The comprehensive exhibits and state-of-the-art display facilities provided the guests with a thorough and profound insight into the company.

      Subsequently, the Health Industry Branch Council (Enlarged) Meeting was successfully held in the Multi-function Hall. At the meeting, President Luo Wenhua expressed his gratitude for Tianyuan Biotech’s warm hospitality and fully affirmed the company’s leading achievements in cell technology, noting that the cell industry is ushering in vigorous development opportunities. He remarked that Tianyuan Biotech’s innovative accomplishments in biomedical technology and its rigorous scientific spirit have set a fine example for the entire health industry. This visit has laid a solid foundation for future industrial cooperation, and both parties look forward to broader and deeper exchanges in the field of cell technology to jointly promote the development of the health industry.

      As the founder and Secretary-General of the Health Industry Branch, General Manager Jiao Mingming extended a warm welcome and heartfelt thanks to President Luo and all attending guests. He stated that Tianyuan Biotech will continue to be driven by technological innovation, upholding the philosophy of "turning the impossible into possible, the possible into value, and value into universal benefit." The company remains committed to continuously enhancing its research strength and contributing to the progress of the health industry. Meanwhile, the company looks forward to collaborating with member units of the Health Industry Branch in areas such as technology R&D, market expansion, and health management to achieve mutual benefit and win-win outcomes.

      The inspection visit by guests from the Health Industry Branch of the Ningbo Vocational Association and the successful convening of the Council (Enlarged) Meeting have not only strengthened communication and cooperation between both parties but also created new opportunities for Tianyuan Biotech’s development in the health industry. Looking ahead, Tianyuan Biotech will continue to focus on technological innovation and customer needs, making unremitting efforts to drive the high-quality development of the health industry.

      Founded in 2017, Zhejiang Tianyuan Biotechnology Co., Ltd. is a national high-tech enterprise dedicated to cell research and development, manufacturing, operations, and services. The company possesses valuable resource banks, including an HLA Umbilical Cord Matching Bank, an iPS Seed Cell Bank, and a Tumor Cell Bank. It is also a participating unit in formulating the group standard for immune function assessment methods under the National Health Commission (NHC). Furthermore, Tianyuan Biotech has co-established the Joint Laboratory for Metabolic Immune Monitoring with the NHC Research Institute, and serves as key research service platforms such as the Ningbo Storage Center of the National Stem Cell Translational Resource Bank and the Achievement Transformation Center of the NHC Research Institute.